The article reviews clinical trials on the effectiveness of combination therapy with 5-reductase inhibitors and -blockers in men with benign prostatic hyperplasia (BPH). These trials have demonstrated a significant improvement in the symptoms and quality of life in this group of patients. The authors outline main strategies offered by the Russian clinical guidelines for BPH patients.
Urologiia (Moscow, Russia : 1999). 2017 Sep [Epub]
A Z Vinarov, L G Spivak, A V Mironov
I.M. Sechenov First MSMU of Minzdrav of Russia, Moscow, Russia.